Status:
COMPLETED
Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Ill Patients
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Glucose Metabolism Disorders
Diabetic Blood Glucose Monitoring
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Critically ill patients are on high risk for increased serum glucose levels, leading to more comorbidity and higher mortality risk. In patients with severe sepsis and septic shock hyperglycemia is a t...
Eligibility Criteria
Inclusion
- critically ill patients with expected ICU stay for more than 72 hours
- informed consent by the patients or legal proxy
Exclusion
- age \< 18
- no informed consent by the patients or legal proxy
- pregnancy
- infaust prognosis
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02296372
Start Date
November 1 2014
End Date
June 1 2016
Last Update
February 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charite University, Berlin, Germany
Berlin, Germany, 13353